UK markets open in 2 hours 12 minutes
NIKKEI 225
38,755.31 +519.24 (+1.36%) HANG SENG
18,420.38 -157.92 (-0.85%) CRUDE OIL
78.61 +0.13 (+0.17%) GOLD FUTURES
2,330.50 -0.70 (-0.03%) DOW
38,852.27 +176.59 (+0.46%) Bitcoin GBP
50,514.26 -481.77 (-0.94%)
Suven Pharmaceuticals Limited (SUVENPHAR.NS)
NSE - NSE Real-time price. Currency in INR
Add to watchlist
As of 10:18AM IST. Market open.
Currency in INR
Valuation measures4
| Market cap (intra-day) | 170.86B |
| Enterprise value | 166.73B |
| Trailing P/E | 46.13 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 15.01 |
| Price/book (mrq) | 8.84 |
| Enterprise value/revenue | 14.63 |
| Enterprise value/EBITDA | 30.02 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.37 |
| 52-week change 3 | 40.75% |
| S&P500 52-week change 3 | 24.49% |
| 52-week high 3 | 768.00 |
| 52-week low 3 | 469.45 |
| 50-day moving average 3 | 649.60 |
| 200-day moving average 3 | 614.20 |
Share statistics
| Avg vol (3-month) 3 | 487.82k |
| Avg vol (10-day) 3 | 152.17k |
| Shares outstanding 5 | 254.56M |
| Implied shares outstanding 6 | 257.3M |
| Float 8 | 95.62M |
| % held by insiders 1 | 62.52% |
| % held by institutions 1 | 20.39% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 09 Sept 2022 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 25 Sept 2020 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Mar 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 31.76% |
| Operating margin (ttm) | 23.83% |
Management effectiveness
| Return on assets (ttm) | N/A |
| Return on equity (ttm) | 21.29% |
Income statement
| Revenue (ttm) | 11.68B |
| Revenue per share (ttm) | 45.88 |
| Quarterly revenue growth (yoy) | -37.90% |
| Gross profit (ttm) | N/A |
| EBITDA | 5.03B |
| Net income avi to common (ttm) | 3.71B |
| Diluted EPS (ttm) | 14.58 |
| Quarterly earnings growth (yoy) | -56.60% |
Balance sheet
| Total cash (mrq) | 7.54B |
| Total cash per share (mrq) | 29.65 |
| Total debt (mrq) | 345M |
| Total debt/equity (mrq) | 1.74% |
| Current ratio (mrq) | 26.98 |
| Book value per share (mrq) | 77.98 |
Cash flow statement
| Operating cash flow (ttm) | N/A |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.